Publication | Closed Access
An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor
66
Citations
6
References
2017
Year
This study highlights the prevalence of adverse effects in a CF population newly exposed to lumacaftor/ivacaftor and demonstrates a relatively high rate of drug intolerance.
| Year | Citations | |
|---|---|---|
Page 1
Page 1